Clinical Trials on 乳房密度 >25% in New Zealand
总计2140个结果
-
Hoffmann-La Roche完全的
-
University of Auckland, New Zealand完全的
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, Australia完全的
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.终止
-
Zealand University HospitalCopenhagen University Hospital, Denmark完全的
-
ETOP IBCSG Partners Foundation完全的
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharma完全的
-
ETOP IBCSG Partners Foundation完全的乳腺癌 | 骨质疏松症法国, 意大利, 瑞士, 澳大利亚, 秘鲁, 西班牙, 新西兰, 南非
-
ETOP IBCSG Partners Foundation完全的
-
Weill Medical College of Cornell UniversityIcahn School of Medicine at Mount Sinai; The Cleveland Clinic; Boston Medical Center未知
-
ETOP IBCSG Partners Foundation完全的
-
University of Rochester完全的
-
Monash UniversityRoyal Perth Hospital招聘中
-
Ontario Clinical Oncology Group (OCOG)U.S. Army Medical Research and Development Command; Supportive Cancer Care Research Unit完全的
-
Case Western Reserve UniversityNational Eye Institute (NEI); Jaeb Center for Health Research完全的
-
GlaxoSmithKline完全的肿瘤,乳腺美国, 以色列, 西班牙, 澳大利亚, 加拿大, 新西兰, 英国, 法国, 突尼斯
-
ETOP IBCSG Partners Foundation终止
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey主动,不招人IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)完全的0 期乳腺癌 | I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌美国
-
National Cancer Institute (NCI)终止复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 男性乳腺癌美国
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)完全的0 期乳腺癌 | 癌症幸存者 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌美国
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的炎性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 浸润性小叶乳腺癌 | 浸润性导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌美国
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University Cancer Institute完全的HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌美国
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics Biotech招聘中解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 三阴性乳腺癌 | 转移性三阴性乳腺癌 | 局部晚期乳腺癌美国
-
National Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌美国
-
Memorial Sloan Kettering Cancer Center招聘中
-
National Cancer Institute (NCI)完全的IV 期乳腺癌 AJCC v6 和 v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 转移性乳腺癌美国
-
National Cancer Institute (NCI)完全的I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; ETOP IBCSG Partners Foundation完全的